U.S. FDA To Open Offices In China As Early As September; India Next
This article was originally published in PharmAsia News
Executive Summary
U.S. and China are close to finalizing plans to open U.S. FDA offices in China, and FDA could have "boots on the ground" as early as September, according to Murray Lumpkin, FDA's deputy commissioner for international and special Programs
You may also be interested in...
U.S. FDA China Country Head Chris Hickey On FDA's Mission In China: An Interview With PharmAsia News (Part 2 of 2)
U.S.FDA established offices in China in 2008 to improve oversight of products exported to the U.S., and to establish stronger working relationships with China's State FDA. The mission of the office initially was to implement two export agreements signed with China in December 2007 to enhance regulatory cooperation in the areas of food, drugs, medical devices and animal feed. PharmAsia News' China and Australia bureaus spoke to FDA China Country Director Christopher Hickey about the mission of the China office and progress being made in China. This is part two of a two-part interview; part one appeared in a recent issue of PharmAsia News.
U.S. FDA China Country Head Chris Hickey On FDA's Mission In China: An Interview With PharmAsia News (Part 2 of 2)
U.S.FDA established offices in China in 2008 to improve oversight of products exported to the U.S., and to establish stronger working relationships with China's State FDA. The mission of the office initially was to implement two export agreements signed with China in December 2007 to enhance regulatory cooperation in the areas of food, drugs, medical devices and animal feed. PharmAsia News' China and Australia bureaus spoke to FDA China Country Director Christopher Hickey about the mission of the China office and progress being made in China. This is part two of a two-part interview; part one appeared in a recent issue of PharmAsia News.
Parexel Consulting Corporate VP Alberto Grignolo On Conducting Clinical Trials In China, India And Asia: An Interview With PharmAsia News
Parexel Consulting Corporate VP Alberto Grignolo recently spoke with PharmAsia News about Asia's evolving clinical trial environment - including the launch of U.S. FDA offices in Asia and the prospect of multinational companies conducting Phase I trials in India. Parexel works with life sciences companies to create clinical development strategies as well as Good Clinical Practices and Good Manufacturing Practices compliance.